Niranjan Y. Sardesai
2017
In 2017, Niranjan Y. Sardesai earned a total compensation of $1.5M as Chief Operating Officer at Inovio Pharmaceuticals, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,750 |
|---|---|
| Option Awards | $437,586 |
| Salary | $435,051 |
| Stock Awards | $450,078 |
| Other | $9,153 |
| Total | $1,480,618 |
Sardesai received $450.1K in stock awards, accounting for 30% of the total pay in 2017.
Sardesai also received $148.8K in non-equity incentive plan, $437.6K in option awards, $435.1K in salary and $9.2K in other compensation.
Rankings
In 2017, Niranjan Y. Sardesai's compensation ranked 7,050th out of 14,666 executives tracked by ExecPay. In other words, Sardesai earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,050 out of 14,666 | 52nd |
Division Manufacturing | 2,616 out of 5,772 | 55th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 342 out of 859 | 60th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 173 out of 531 | 67th |
Industry Surgical and Medical Instruments and Apparatus | 105 out of 336 | 69th |
Source: SEC filing on March 28, 2018.
Sardesai's colleagues
We found three more compensation records of executives who worked with Niranjan Y. Sardesai at Inovio Pharmaceuticals in 2017.